HRSA posts a revised 340B Rebate Model Pilot in the Federal Register, ten days after the appellate ruling that put the Secretary in control of rebate mechanisms
HRSA's 340B Rebate Model Pilot Program page, read August 1, 2026, states: "On July 31, 2026, the Health Resources and Services Administration (HRSA) posted a Notice Regarding 340B Rebate Model Pilot Program in the Federal Register to announce the availability of a revised 340B Rebate Model Pilot Program (Pilot)." HRSA describes the Pilot as providing "a rebate mechanism through which qualifying manufacturers may effectuate the 340B ceiling price for certain drugs sold to covered entities," says it is "limited to a select group of drugs and is open to qualifying manufacturers that submit plans meeting specific criteria," and directs qualifying manufacturers to submit plans to the Office of Pharmacy Affairs.
WHY THIS MATTERS HERE: the first rebate pilot was vacated and remanded to HRSA in February 2026, and the advocacy entry for the July 21 appellate ruling said to watch for any HHS move to authorize a rebate pilot of its own. This is that move, and it arrives via the exact authority the court described.
SCOPE LIMITS, STATED PLAINLY: the HRSA page names no drugs, no effective date, and no comment or plan-submission deadline. Those terms sit in the linked Federal Register notice PDF, which was NOT read for this item because the Federal Register page returned a bot-check interstitial.
Trade reporting circulating a drug count and a start date is therefore deliberately not carried here, and the page makes no statement about operational consequences for covered entities. Confirm the terms against the notice PDF before acting on it.
Primary source
HRSA Office of Pharmacy AffairsSource packet
This story's primary source + 4 related tracked stories with theirs — one print-ready digest for your team or board packet.
Free — subscribes you to the Intel Brief. Individual sources are always clickable above, no email needed.
This story will move — get the follow-up
The FQHC Intel Brief traces every claim to a primary source, like the one above. Free.
You are signing up for the newsletter you choose, a short welcome sequence, occasional product updates, and one-click unsubscribe. We do not sell your email. Privacy Policy · Do Not Sell/Share
FQHC Talent. (2026, July 31). HRSA posts a revised 340B Rebate Model Pilot in the Federal Register, ten days after the appellate ruling that put the Secretary in control of rebate mechanisms. Primary source: HRSA Office of Pharmacy Affairs. Retrieved August 1, 2026, from https://www.fqhctalent.com/intel/hrsa-revised-340b-rebate-model-pilot-posted-july-2026
More in Funding & Budget
Dec 31
CalAIM Section 1115 Waiver Expires December 2026 — $1.2B/Year at Stake
Jul 30
Central California Alliance for Health opens Round 3 of its capacity grants — CHW recruitment, provider recruitment, and health IT — with an August 18 deadline
Jul 28
The ACA coverage loss stops being a projection: 2.6M fewer people actually paid for marketplace coverage in 2026 — and New Mexico, the one state that replaced the federal subsidies itself, grew 14%
Jul 27
House Energy & Commerce advances $750M in new health-center money 45-0 — the first affirmative CHC funding action of 2026, and it is not law yet